This activity is no longer available for credit, however its content is still relevant for your educational needs.

Target Audience
This activity was developed for pharmacists and other healthcare professionals practicing in a managed care environment.

Learning Objectives
At the completion of this activity participants should be able to:

• Identify the governing dynamics supportive of a robust, productive, and useful R&D process in the emerging healthcare system that is evidence-based, value-based, and patient-centered
• Discuss the business and government cost-management pressures, as well as the new clinical/epidemiologic drivers that are forcing the industry to reexamine how it identifies and develops new drugs
• Summarize the specific role that managed care pharmacy has as a key stakeholder in the R&D process

Disclosure Statement
Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial products(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers’ bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.

The associates of Medical Learning Institute, Inc. have no financial relationships to disclose. The associates of Center of Excellence Media, LLC, have no financial relationships to disclose.

Faculty Disclosures
Thomas McCarter, MD, FACP has nothing to disclose.

Nirav Shah, MD, MPH, FACP has received research honoraria from AstraZeneca, Merck, and Roche.

Kip Piper, MA, FACHE is a consultant for bioMerieux, NovoNordisk, Pfizer, Phillips, and Wyeth, and has received research honorarium from Wyeth.

Matthew Sarnes, PharmD is a consultant for Allergan, AMAG Pharmaceuticals, Bristol-Myers Squibb, GlaxoSmithKilne, Novartis, NuPathe, Qmed, sanofi-aventis, Santhera, Shire, Smith & Nephew, ViroPharma, and Wyeth.

Michael Murphy, MD, PhD has nothing to disclose.


*Content will include non-FDA-approved uses.

Disclaimer
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.